Evaluation of the Serum Levels of Interleukin-6, Interleukin-10, and C-Reactive Protein in Iraqi Women with Breast Cancer
DOI:
https://doi.org/10.36320/ajb/v15.i3.13646Keywords:
Biochemical parameters, Immunity response, Breast cancerAbstract
Breast cancer is the most prevalent form of cancer in women and is the leading cause of global cancer-related mortality. The study aimed to assess the changes in some serum biomarkers linked to immunity responses in Iraqi breast cancer patients and understand their multifaceted role in the disease's progression. The current investigation comprised a cohort of 55 women diagnosed with breast cancer and a control group of 45 healthy participants. The levels of interleukin-6 (IL-6), interleukin-10 (IL-10), and C-reactive protein (CRP) were estimated in the serum of breast cancer patients. The results showed that patients with breast cancer had a significant increase (p<0.05) in IL-6, IL-10, and CRP serum concentrations as compared to healthy women. These findings give support to the evidence suggesting that these markers may play an essential role in the progression of breast cancer.
Downloads
References
American Cancer Society (ACS) (2018). Global Cancer: Facts and Figures. American Cancer Society report. 4th Edition. Atlanta. US. No. 861818.
American Cancer Society (2023). Cancer Facts & Figures 2023. American Cancer Society report. Atlanta.US.cancer.org | 1.800.227.2345.
Lamy, P.J., Durigova, A., & Jacot, W. (2014). Iron homeostasis and anemia markers in early breast cancer. Iron and breast cancer. Clinica Chimica Acta, 434:34-40. DOI: https://doi.org/10.1016/j.cca.2014.04.011
Sheikhpour, E., Noorbakhsh, P., Foroughi, E., Farahnak, S., Nasiri, R., et al. (2018). A survey on the role of interleukin-10 in breast cancer: A narrative. Reports of Biochemistry & Molecular Biology, 7(1): 30-37.
Chen, J., Wei, Y., Yang, W., Huang, Q., Chen, Y., et al. (2022). IL-6: the link between inflammation, immunity and breast cancer. Frontiers in Oncology, 12:1-11. DOI: https://doi.org/10.3389/fonc.2022.903800
Sproston, N. R., & Ashworth, J. J. (2018). Role of C-Reactive protein at sites of inflammation and infection. Frontiers in Immunology, 9:1-11. DOI: https://doi.org/10.3389/fimmu.2018.00754
Ciubotaru, I., Potempa, L.A., & Wander, R.C. (2005). Production of modified C-reactive protein in U937-derived macrophages. Experimental Biology & Medicine, 230(10):762-770. DOI: https://doi.org/10.1177/153537020523001010
El-Abd, E., El-Sheikh, M., Zaky, S., Fayed, W., & El-Zoghby, S. (2017). Plasma TuM2-PK correlates with tumor size, CRP and CA 15-3 in metastatic breast carcinomas; short versus long term follow up study of the Egyptian breast cancer patients. Cancer Biomarkers, 20(2):123-133. DOI: https://doi.org/10.3233/CBM-160482
Chen, L., Kong, X., Yan, C., Fang, Y., & Wang, J. (2020). The research progress on the prognostic value of the common hematological parameters in peripheral venous blood in breast cancer. Onco Targets and Therapy, 13:1397-1412. DOI: https://doi.org/10.2147/OTT.S227171
Theml, H., Diem, H., & Haferlach, T. (2004). Color Atlas of Hematology; Practical Microscopic and Clinical Diagnosis. 5th German edition. Thieme Verlag, Stuttgart, Germany. Translator: Ursula Peter-Czichi PhD, Atlanta, GA, USA. DOI: https://doi.org/10.1055/b-005-148949
Kozłowski, L., Zakrzewska, I., Tokajuk, P., Wojtukiewicz, M.Z. (2003). Concentration of interleukin-6 (Il-6), interleukin-8 (Il-8) and interleukin-10 (Il-10) in blood serum of breast cancer patients. Annales Academiae Medicae Bialostocensis, 48:82-84.
AL-thwani, A. N. A., & Mohsin, S. M. (2012). Serum level of interleukin-6 in breast cancer Iraqi women. Iraqi Journal of Cancer and Medical Genetics, 5(1): 42-45. DOI: https://doi.org/10.29409/ijcmg.v5i1.77
AL-Humesh, M.J.M. (2013). Study of the changes in sexual hormones levels and a number of immune parameters of women with breast cancer and ovary cancer. Tikrit Journal of Pure Sciences, 1(18):95-102.
Dinarello, C. A. (2007). Historical insights into cytokines. European Journal of Immunology, 37(S1):34-45. DOI: https://doi.org/10.1002/eji.200737772
Wautier, J. L., & Wautier, M. P. (2023). Pro-and anti-inflammatory prostaglandins and cytokines in humans: A mini review. International Journal of Molecular Sciences, 24(11):1-13. DOI: https://doi.org/10.3390/ijms24119647
Habanjar, O., Bingula, R., Decombat, C., Assaf, M. D., Caldefie-Chezet F. & Delort, L. (2023). Crosstalk of inflammatory cytokines within the breast tumor microenvironment. International Journal of Molecular Sciences, 24:1-40. DOI: https://doi.org/10.3390/ijms24044002
Martínez-Pérez, C., Kay, C., Meehan, J., Gray, M., J., Dixon, M., & Turnbull, A. K. (2021). The IL6-like cytokine family: role and biomarker potential in breast cancer. Journal of Personalized Medicine,11:1-32. DOI: https://doi.org/10.3390/jpm11111073
Felcher, C. M., Bogni, E. S., & Kordon, E. C. (2022). IL-6 cytokine family: A putative target for breast cancer prevention and treatment. International Journal of Molecular Sciences, 23:1-15. DOI: https://doi.org/10.3390/ijms23031809
Hirano, T. (2020). IL-6 in inflammation, autoimmunity and cancer. International Immunology, 33(3):127-148. DOI: https://doi.org/10.1093/intimm/dxaa078
Bachelot, T., Ray-Coquard, I., Menetrier-Caux, C., Rastkha, M., Duc, A., & Blay, J. Y. (2003). Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. British Journal of Cancer, 88(11):1721-1726. DOI: https://doi.org/10.1038/sj.bjc.6600956
Salgado, R.; Junius, S.; Benoy, I.; Van Dam, P.; Vermeulen, P.; Van Marck, E.; Huget, P.; & Dirix, L.Y. (2003). Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. International Journal of Cancer, 103(5): 642-646. DOI: https://doi.org/10.1002/ijc.10833
Ahmad, N., Ammar, A., Storr, S. J., Green, A. R., Rakha, E., et al. (2018). IL-6 and IL-10 are associated with good prognosis in early-stage invasive breast cancer patients. Cancer Immunology & Immunotherapy, 67(4):537-549. DOI: https://doi.org/10.1007/s00262-017-2106-8
Salman, A. H., Iqbal, M. N., & Bakir, W.A., (2008). The in situ expression of IL-6 and IL-1β in breast cancer patients. Iraqi Journal of Pharmaceutical Sciences, 17(2):55-62. DOI: https://doi.org/10.31351/vol17iss2pp55-62
Baker, L. A. (2014). Determination of some biochemical markers in patients with breast cancer. Tikrit Journal of Pure Sciences,19(5):27-31.
Petekkaya, I., Unlu, O., Roach, E. C., Gecmez, G., & Okoh, A. K. (2017). Prognostic role of inflammatory biomarkers in metastatic breast cancer. Journal of Balkan Union of Oncology, 22(3):614-622
eorge, A., Bobby, Z., & Dubashi, B. (2021). Utility of ferritin and inflammatory biomarkers in the diagnosis of different stages of breast cancer. Saudi Medical Journal, 42(8):825-831. DOI: https://doi.org/10.15537/smj.2021.42.8.20210244
Rossi, J., Lu, Z., Jourdan, M., & Klein, B. (2015). Interleukin-6 as a therapeutic target. Clinical Cancer Research, 21(6):1248-1257. DOI: https://doi.org/10.1158/1078-0432.CCR-14-2291
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ashjan Ibraheem Muhesin, Abdul-Hadi Abbas Hadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
